IRVINE, Calif., Aug. 4 Cardiogenesis Corporation (OTCQB: CGCP), a leading developer of surgical products used to treat cardiac patients suffering from severe angina, today reported financial results for its second quarter and first half ...
RAMSEY, N.J. , Aug. 4 /PRNewswire/ -- CardioTec is the first and only conference dedicated to addressing the challenges facing the cardiovascular device manufacturing industry. Hosted by Medical Product Outsourcing magazine, CardioTec ...
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position. The association makes no ...
CardioMag Imaging, Inc. 450 Duane Avenue Schenectady, NY 12304 Phone (518) 381-1000 Fax (518) 381-1101 [email protected] ...
STAMFORD, Conn. , July 30 /PRNewswire-FirstCall/ -- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (OTCQB: SPDE), today announced that the VA Palo Alto Health Care System (VAPAHCS), a northern California based hospital ...
Q2 Revenue of $36.1 Million Reconciliation of Net Loss Attributable to Cardiac Science Corporation to Pro Forma Net Loss Attributable to Cardiac Science Corporation Three ...
MONT-SAINT-GUIBERT, Belgium, July 29, 2010 - This press release is issued to clarify a Cardio3 BioSciences release of July 14, 2010. Cardio3 BioSciences, a leading Belgian biotechnology company specialising in regenerative therapies for the ...
VANCOUVER, July 28 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) ("Angiotech") and partner Athersys, Inc. (NASDAQ: ATHX) announced positive results from its phase I clinical trial of MultiStem(R), its allogeneic ...
BOTHELL, Wash., July 27 Cardiac Science Corporation (Nasdaq: CSCX), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, today announced the introduction of two new products that extend its ...
BASKING RIDGE, N.J., July 26 Regado Biosciences, Inc., a privately held biopharmaceutical company pioneering the development of a novel two-component antithrombotic drug technology consisting of therapeutic aptamers with their matched ...
A mRNA injection to boost heart attack recovery by encouraging blood vessel growth and muscle repair.
Discover how light-controlled ink in bioprinted tissues offers a non-invasive method for heart repair, revolutionizing cardiac therapy and tissue regeneration.
KFSHRC performs the world’s first robotic-assisted artificial heart pump implantation, revolutionizing heart care with precision, faster recovery, and minimal scarring.
High aircraft noise near airports may increase the risk of heart problems, including heart attacks and strokes.
UVA researchers are using a new MRI technique to analyze fat around the heart, helping identify at-risk patients and improve heart disease treatment.
Subscribe to our Free Newsletters!